Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Post-operative opioid dosing relative to preoperative long-acting opioid dose. / Uhrbrand, Peter; Papadomanolakis-Pakis, Nicholas; Nikolajsen, Lone.
In: Danish Medical Journal, Vol. 69, No. 8, A02220076, 08.2022.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
}
TY - JOUR
T1 - Post-operative opioid dosing relative to preoperative long-acting opioid dose
AU - Uhrbrand, Peter
AU - Papadomanolakis-Pakis, Nicholas
AU - Nikolajsen, Lone
N1 - Publisher Copyright: © 2022, Almindelige Danske Laegeforening. All rights reserved.
PY - 2022/8
Y1 - 2022/8
N2 - INTRODUCTION. Acute post-operative pain treatment continues to pose a primary therapeutic challenge for clinicians, particularly in opioid-tolerant patients. The purpose of this study was to examine whether patients with a high total daily intake of long-acting opioids received the recommended PRN opioid doses in the first 24 hours after surgery. METHODS. This was a retrospective cohort study using a comprehensive hospital database at the Aarhus University Hospital, Denmark. Patients who received both slow-release long-acting and PRN opioids within the first 24 hours after inpatient surgery were included. Patients were defined as having a high intake if they received slow-release opioids ≥ 60 mg morphine equivalents (MME). RESULTS. In total, 199 patients (14%) received a 24-hour dose of slow-release long-acting opioids ≥ 60 MME and 1,247 patients (86%) received < 60 MME. The median age was 64 years (interquartile range: 49-74 years); 54% were female. Patients in the ≥ 60 MME group were less likely to receive the recommended first PRN dose (at least 10% of total 24-hour dose) within the first 24 hours after surgery (79 patients; proportion = 0.40, 95% confidence interval (CI): 0.33-0.47 versus 129 patients; proportion = 0.10, 95% CI: 0.09-0.12, p < 0.001). CONCLUSIONS. Our results suggest that patients with a high intake of long-acting opioids may be more likely to receive PRN opioid doses that are not sufficiently adjusted to their total intake during the first 24 hours after inpatient surgery than patients with a lower intake of long-acting opiods.
AB - INTRODUCTION. Acute post-operative pain treatment continues to pose a primary therapeutic challenge for clinicians, particularly in opioid-tolerant patients. The purpose of this study was to examine whether patients with a high total daily intake of long-acting opioids received the recommended PRN opioid doses in the first 24 hours after surgery. METHODS. This was a retrospective cohort study using a comprehensive hospital database at the Aarhus University Hospital, Denmark. Patients who received both slow-release long-acting and PRN opioids within the first 24 hours after inpatient surgery were included. Patients were defined as having a high intake if they received slow-release opioids ≥ 60 mg morphine equivalents (MME). RESULTS. In total, 199 patients (14%) received a 24-hour dose of slow-release long-acting opioids ≥ 60 MME and 1,247 patients (86%) received < 60 MME. The median age was 64 years (interquartile range: 49-74 years); 54% were female. Patients in the ≥ 60 MME group were less likely to receive the recommended first PRN dose (at least 10% of total 24-hour dose) within the first 24 hours after surgery (79 patients; proportion = 0.40, 95% confidence interval (CI): 0.33-0.47 versus 129 patients; proportion = 0.10, 95% CI: 0.09-0.12, p < 0.001). CONCLUSIONS. Our results suggest that patients with a high intake of long-acting opioids may be more likely to receive PRN opioid doses that are not sufficiently adjusted to their total intake during the first 24 hours after inpatient surgery than patients with a lower intake of long-acting opiods.
KW - Analgesics, Opioid/therapeutic use
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Pain, Postoperative/drug therapy
KW - Postoperative Period
KW - Retrospective Studies
M3 - Journal article
C2 - 35959832
VL - 69
JO - Danish Medical Journal
JF - Danish Medical Journal
SN - 2245-1919
IS - 8
M1 - A02220076
ER -